Transcripts Decoy Therapeutics Inc.

Actions

Marché Fermé - Nasdaq 22:00:00 18/09/2026			Varia. 5j.	Varia. 1 janv.
2,780 ^USD	-1,77 %		+4,12 %	-64,29 %

12/08	Decoy Therapeutics Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
27/07	Decoy Therapeutics démontre l'activité in vitro de son candidat D-MAV contre le virus Ebola Zaïre de type sauvage et lance un programme exploratoire contre les filovirus, dont Ebola et Marburg	CI

09/04	Transcript : Decoy Therapeutics Inc. - Special Call
14/12/22	Transcript : Salarius Pharmaceuticals, Inc. - Special Call
08/08/22	Transcript : Salarius Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 08, 2022
12/05/22	Transcript : Salarius Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
10/03/22	Transcript : Salarius Pharmaceuticals, Inc., Q4 2021 Earnings Call, Mar 10, 2022
13/01/22	Transcript : Salarius Pharmaceuticals, Inc. - Special Call
04/11/21	Transcript : Salarius Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 04, 2021
05/08/21	Transcript : Salarius Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 05, 2021
21/06/21	Transcript : Salarius Pharmaceuticals, Inc. - Special Call
18/03/21	Transcript : Salarius Pharmaceuticals, Inc., Q4 2020 Earnings Call, Mar 18, 2021
01/09/20	Transcript : Salarius Pharmaceuticals, Inc. Presents at LD Micro 500 Virtual Investor Conference, Sep-01-2020 03:20 PM
12/08/20	Transcript : Salarius Pharmaceuticals, Inc., Q2 2020 Earnings Call, Aug 12, 2020
17/02/20	Transcript : Salarius Pharmaceuticals, Inc. Presents at 16th Annual Noble Conference Emerging Growth Investor Conference, Feb-17-2020 05:00 PM